Siemens Showcases Quantitative Solutions For Preclinical Translational Research At WMIC

Main Category: Medical Devices / Diagnostics
Article Date: 10 Sep 2010 - 6:00 PDT


Siemens Healthcare Molecular Imaging is showcasing its portfolio of clinical and preclinical imaging and biomarker solutions at the World Molecular Imaging Congress from September 7-10 (booth #514). The exhibit highlights "Quantitative Solutions in Translational Research," demonstrating how Siemens is focused on enabling researchers to speed discovery to clinical adoption, ultimately, improving healthcare. In addition to featuring preclinical imaging products that enable highly quantitative studies, Siemens is also hosting an industry workshop that highlights recent research and discovery efforts on moving translational research into clinical practice. The workshop speakers will discuss applications performed on Siemens Inveon™ preclinical imaging platform and update the status of novel biomarkers in development at Siemens Molecular Imaging Biomarker Research facility.

"Siemens Molecular Imaging, with its comprehensive suite of solutions from innovative biomarkers, chemistry and distribution solutions, preclinical imaging and clinical products, is committed to enabling breakthrough translational research from discovery, validation to clinical realization and practice," said Kirti Patel, vice president, Siemens Preclinical Solutions. "Our goal is to enable a fundamental understanding of biological functions and processes, ultimately, leading to breakthrough discoveries in molecular diagnosis and therapy."

The company's latest imaging solutions displayed at WMIC include:

Inveon Preclinical Imaging - The modular Inveon preclinical discovery platform allows users to combine positron emission tomography (PET), single photon emission computed tomography (SPECT), and computed tomography (CT) acquisition systems in one unit. This scalable system also offers high-quality PET resolution and sensitivity, delivering valuable knowledge for a powerful impact. New at WMIC, Siemens showcases Inveon's suite of new SPECT collimators and associated pyramids to enable whole-body rat imaging. The collimator sets include collimators for general purpose, as well as high sensitivity and high resolution SPECT preclinical imaging. This new set of collimators completes the entire suite of collimators necessary for high performance SPECT imaging applications and is supported by the latest version of Inveon Acquisition Workplace.

Inveon Acquisition Workplace (IAW) 1.5 - With the release of IAW1.5, Inveon hosts a suite of research and workflow tools that maximizes the efficiency of data acquisition and reconstruction, and thus improves overall productivity. It also includes a new reconstruction algorithm, OP-MAP, for low-dose PET studies. OP-MAP enables quantitative dynamic studies using low dose and low counts from injected tracer. In combination with fastMAP™ algorithm, OP-MAP is capable of performing much faster reconstructions and enabling significant improvements in overall workflow. The addition of OP-MAP algorithm solidifies Siemens Preclinical Solutions leadership position in PET imaging by providing the largest number of PET reconstruction algorithms in the industry*.

Preclinical Solutions Molecular Imaging University - Preclinical Solutions Molecular Imaging University is an online resource of educational and training materials designed to serve as a guide for researchers interested in adopting and learning about the applications of preclinical PET, SPECT and CT imaging to their research. Access to this valuable resource will simplify many of the concepts of these powerful technologies. This resource tool will be updated on a regular basis.

*Data on file

Source:
Siemens Healthcare

• Additional
• References
• Citations